Katz Richard D 4
4 · ARGOS THERAPEUTICS INC · Filed Apr 25, 2018
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2018-04-25−22,629→ 9,697 total
Footnotes (1)
- [F1]Represents shares forfeited upon the delisting of the Company's common stock from The Nasdaq Capital Market.